Description
SYNVISC® 8 mg/2 mL es un dispositivo médico de administración intraarticular que contiene Hylan G-F 20
un agonista del receptor CXCR4
No agitar ni mezclar con otras soluciones
PRINCIPIO ACTIVO: RIVAROXABAN
FORMA FARMACÉUTICA: 6 INYECCIONES
DEPLES .50/.02/3G JBE 60 ML MENTHOLATUM DE MEXICO SYNVISC® 8 mg/2 mL esPRINCIPIO ACTIVO: AMANTADINA, CLORFENAMINA, PARACETAMOL
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
